ClinicalTrials.gg
RecruitingNCT07134569Updated Jan 12, 2026

Motor Function Assessment and VR-based Motor Training in Adults With Autism Spectrum Disorder

An interventional study of VR-based motor training in Autism, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-12.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Dec 2023, registered Feb 2025).
  • Started Dec 2023; still recruiting 2 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Autistic Disorder by National Taiwan University Hospital — 6 open to participants now, 6 under way, none of them phase 3. Autistic Disorder · National Taiwan University Hospital.

Started
2023
with 1 other
No phase
6 of 12
3 open now
Registered
10th of 12
by date

Among the 12 studies in Autistic Disorder by National Taiwan University Hospital, this one is one of 2 that started in 2023, is one of 6 with no phase, and was the 10th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

6 of the 12 studies in Autistic Disorder by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Autistic Disorder by National Taiwan University Hospital, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if autism affect motor functions, including muscle strength, balance, and motor control? Additionally, understanding the motor functions, cognitive functions, and brain activation in individuals with autism, and verifying whether motor training can effectively improve muscle strength, balance, and motor control. The main questions aim to answer are:

[primary hypothesis or outcome measure 1]? [primary hypothesis or outcome measure 2]? If there is a comparison group: Researchers will compare [arm information] to see if [insert effects].

Participants will [describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items].

03

Conditions studied

  • Autism

Browse trials for

Keywords

  • Virtual Reality
  • motor training
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

> The ASD Group

Inclusion criteria:

  • young adult aged between 18 and 45 years who had a diagnosis of ASD from a licensed mental health or medical professional based on .
  • was motivated to complete the 6-week VR-based motor function training.
  • had a full-scale IQ > 70 on the WAIS-IV.

Exclusion criteria:

  • a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radiculopathy, or spinal cord injury) that hamper walking function, or neurosurgery.
  • visual impairment and/or hearing impairment that would preclude participation in motor assessment or training.

    • The Non-ASD control group

Inclusion criteria:

  • young adult aged between 18 and 45 years who do not have a diagnosis of ASD.
  • had a full-scale IQ > 70 on the WAIS-IV.

Exclusion criteria:

  • a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radiculopathy, or spinal cord injury), or neurosurgery that hamper walking function.
  • visual impairment and/or hearing impairment that would preclude participation in motor assessment or training.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Autism

    Behavioral: VR-based motor training

  • No intervention
    Typically developing control

Interventions

  • BehavioralVR-based motor training

    Six weeks, twice per week.

06

What researchers measure

Primary outcomes

  1. The performance of movement operational assessment

    Participants will take movement operational assessment, which composed of different tests, such as Timed Up and Go Test (TUG), the 10-meter walk test (10MWT) and the 6-minute walk test (6WMT)

    Time frame: 40 minutes

  2. The performance of motor coordination control

    the performance recorded with Vicon, an motion capture system, and Single Leg Stance Test

    Time frame: 1 hour, twice

Secondary outcomes

  1. The N-back Task performance

    Time frame: 40 minutes

  2. The performance of Timed Up and Go Test (TUG)

    Time frame: 1 minute, twice

  3. The performance of the 10-meter walk test (10MWT)

    Time frame: 1 minute, twice

  4. The performance of 6-minute walk test (6WMT)

    Time frame: 6 minutes, twice

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2023 (actual). Primary completion is estimated for Jul 2027, 43 months after the start.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 43 months is above that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2025
First posted
Aug 21, 2025
StartActual
Dec 15, 2023
Primary completionEst.
Jul 31, 2027
CompletionEst.
Jul 31, 2027
Last update
Jan 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07134569
Responsible party
Sponsor
First posted
Aug 21, 2025
Start date
Dec 15, 2023
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Jan 12, 2026

Study contacts

Yi Ling Chien, Clinical Professor
Contact
ntuh.peers@gmail.com
+886 2-23123456 ext. 266013

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion